633
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Mycotic aortic aneurysms: characteristic macroscopic findings in a case series

, , , , &
Article: 2341696 | Received 05 Dec 2023, Accepted 06 Apr 2024, Published online: 14 Apr 2024

References

  • Lee W-K, Mossop PJ, Little AF, et al. Infected (mycotic) aneurysms: spectrum of imaging appearances and management. Radiographics. 2008;28(7):1853–1868. doi: 10.1148/rg.287085054.
  • Sörelius K, di Summa PG. On the diagnosis of mycotic aortic aneurysms. Clin Med Insights Cardiol. 2018;12:1179546818759678. doi: 10.1177/1179546818759678.
  • Osler W. The Gulstonian lectures, on malignant endocarditis. Br Med J. 1885;1(1262):467–470. doi: 10.1136/bmj.1.1262.467.
  • Macedo TA, Stanson AW, Oderich GS, et al. Infected aortic aneurysms: imaging findings. Radiology. 2004;231(1):250–257. doi: 10.1148/radiol.2311021700.
  • Inam H, Zahid I, Khan SD, et al. Hemoptysis secondary to rupture of infected aortic aneurysm – a case report. J Cardiothorac Surg. 2019;14(1):144. doi: 10.1186/s13019-019-0959-y.
  • Chen IM, Chang HH, Hsu CP, et al. Ten-year experience with surgical repair of mycotic aortic aneurysms. J Chin Med Assoc. 2005;68(6):265–271. doi: 10.1016/S1726-4901(09)70148-0.
  • Husmann L, Huellner MW, Gruenig H, et al. Impact of PET/CT among patients with suspected mycotic aortic aneurysms. PLOS One. 2021;16(10):e0258702. doi: 10.1371/journal.pone.0258702.
  • Husmann L, Huellner MW, Ledergerber B, et al. Diagnostic accuracy of PET/CT and contrast enhanced CT in patients with suspected infected aortic aneurysms. Eur J Vasc Endovasc Surg. 2020;59(6):972–981. doi: 10.1016/j.ejvs.2020.01.032.
  • Hsu RB, Chen RJ, Wang SS, et al. Infected aortic aneurysms: clinical outcome and risk factor analysis. J Vasc Surg. 2004;40(1):30–35. doi: 10.1016/j.jvs.2004.03.020.
  • Sörelius K, Wanhainen A, Wahlgren C-M, et al. Nationwide study on treatment of mycotic thoracic aortic aneurysms. Eur J Vasc Endovasc Surg. 2019;57(2):239–246. doi: 10.1016/j.ejvs.2018.08.052.
  • Cullen JM, Booth AT, Mehaffey JH, et al. Clinical characteristics and longitudinal outcomes of primary mycotic aortic aneurysms. Angiology. 2019;70(10):947–951. doi: 10.1177/0003319719858784.
  • Luo Y, Zhu J, Dai X, et al. Endovascular treatment of primary mycotic aortic aneurysms: a 7-year single-center experience. J Int Med Res. 2018;46(9):3903–3909. doi: 10.1177/0300060518781651.
  • Wanhainen A, Verzini F, Van Herzeele I, et al. European Society for Vascular Surgery (ESVS) 2019 clinical practice guidelines on the management of abdominal aorto-iliac artery aneurysms. Eur J Vasc Endovasc Surg. 2019;57(1):8–93. doi: 10.1016/j.ejvs.2018.09.020.
  • Wilson WR, Bower TC, Creager MA, et al. Vascular graft infections, mycotic aneurysms, and endovascular infections: a scientific statement from the American Heart Association. Circulation. 2016;134(20):e412–e460. doi: 10.1161/CIR.0000000000000457.
  • Kan CD, Lee HL, Yang YJ. Outcome after endovascular stent graft treatment for mycotic aortic aneurysm: a systematic review. J Vasc Surg. 2007;46(5):906–912. doi: 10.1016/j.jvs.2007.07.025.
  • Sörelius K, Wanhainen A, Furebring M, et al. Nationwide study of the treatment of mycotic abdominal aortic aneurysms comparing open and endovascular repair. Circulation. 2016;134(23):1822–1832. doi: 10.1161/CIRCULATIONAHA.116.024021.